Bionano Genomics(BNGO) - 2024 Q1 - Quarterly Report

Table of Contents ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-38613 _________________________________________________________ Bionano Genomics, Inc. (Exact name of registrant as specified in its charter) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share BNGO The Nasdaq Stock Market, LLC Large accelerated filer ☐ Accelerated filer ...